Table 1: Main characteristics of the cohort.
Past medical history |
Number |
% |
|
COPD |
28 |
39 |
|
Hypertension |
21 |
30 |
|
Diabetus mellitus |
9 |
13 |
|
Pulmonary post Tuberculous sequellae |
9 |
13 |
|
Gastro-duodenal ulcer |
9 |
13 |
|
Histological subtype |
Number |
% |
|
Squamous cell carcinoma |
18 |
25 |
|
Adenocarcinoma |
41 |
58 |
|
Others |
12 |
17 |
|
Chemotherapy protocol |
Number |
% |
|
Cisplatin - Vinorelbine |
28 |
39 |
|
Cisplatin - Gemcitabine |
23 |
32 |
|
Carboplatin - Paclitaxel |
20 |
29 |
|
Stage |
Number |
% |
|
T |
1c |
1 |
1 |
2b |
9 |
13 |
|
3 |
16 |
23 |
|
4 |
45 |
63 |
|
N |
0 |
11 |
15 |
1 |
9 |
13 |
|
2 |
34 |
48 |
|
3 |
17 |
24 |
|
M |
1a |
19 |
27 |
1b |
24 |
34 |
|
1c |
28 |
39 |
|
Adverse events (AE) |
Number |
% |
|
Neutropenia |
16 |
22 |
|
Vomiting |
9 |
12 |
|
Anemia |
5 |
7 |
|